Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 53,948 | 0 | 0 | 3,345 | 26,290 |
| Cost of Goods | 3,514 | N/A | N/A | N/A | N/A |
| Gross Profit | 50,434 | N/A | N/A | 3,345 | 26,290 |
| Operating Expenses | 130,745 | 95,332 | 47,769 | 44,056 | 59,189 |
| Operating Income | -79,797 | -95,332 | -47,769 | -40,711 | -32,899 |
| Interest Expense | 13,139 | 2,415 | 828 | 1,002 | 1,209 |
| Other Income | -56 | -161 | -3,854 | 1,690 | 4,756 |
| Pre-tax Income | -92,992 | -97,908 | -52,451 | -40,023 | -29,352 |
| Net Income Continuous | -92,992 | -97,908 | -52,451 | -40,023 | -29,352 |
| Minority Interests | N/A | N/A | N/A | 3 | -32 |
| Net Income | $-92,992 | $-97,908 | $-52,451 | $-40,026 | $-29,320 |
| EPS Basic Total Ops | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 |
| EPS Basic Continuous Ops | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 |
| EPS Diluted Total Ops | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 |
| EPS Diluted Continuous Ops | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 |
| EBITDA(a) | $-77,846 | $-94,806 | $-47,237 | $-40,165 | $-32,306 |